Instituto Bernabeu research aimed to determine if any ovarian stimulation factors can be linked to oocyte morphology and to the type of membrane breakage when intracytoplasmic spermatozoa injection (ICSI) is performed. This assisted reproduction technique is routinely used in in vitro fertilisation (IVF) laboratories. It has the huge advantage of providing a helping hand when male patients suffer from severe male factors and it stops sperm counts from being a limitation. However, the main disadvantage is that the results depend to a large degree on the operator performing the technique. Although specialists are currently able to perform the process securely, there are some variations in the results that they obtain. Differences between oocytes in ICSI are observed even when an egg donation programme is used.
The new Instituto Bernabeu Group newsletter is now available. Microbiome analysis in patients with embryo implantation failure.
Instituto Bernabeu in Cartagena is organising a scientific event to address progress in the treatment of uterine fibroids. The event will be held on Friday, 31st January in the graduation room at the Polytechnic University in Cartagena. This is just one of many scientific events that the clinic regularly organises at its Cartagena branch. The purpose of the events is to improve knowledge of reproductive health.
Instituto Bernabeu is set to employ a new technique that helps women under 35 years of age to have children with their own ova. These women are otherwise compelled to turn to egg donation
Instituto Bernabeu's social welfare entity invests over €123,000 in courses of treatment for patients who have limited financial resources. This is over 70% of the €176,000 total spend. It donates €33,500 to NGOs, €14,200 to science and research and €10,000 to student scholarships.
Instituto Bernabeu’s participation in events held in Portugal on 4th and 5th December focused on poor responders and new strategies to help women achieve a pregnancy.
Does the number of oocytes obtained following ovarian puncture have an impact on embryo quality? This is the question that a team of researchers from the Embryology Departments at Instituto Bernabeu in Alicante and Albacete and the genetics laboratory at Biotech asked themselves as they proceeded to study the results obtained in almost 400 cycles of in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). The research work was presented in poster format at the Association for the Study of Reproduction Biology (ASEBIR) Congress, a gathering attended by leading global experts. The research was based on the relationship between the number of oocytes obtained following ovarian puncture and the results of IVF treatment.
Dr Rafael Bernabeu, Medical Director at Instituto Bernabeu, gave a speech within the framework of the ‘Review and updated handling of recurrent pregnancy loss’ course held in Madrid. The event was organised by the Spanish Society of Gynaecology and Obstetrics (SEGO).
A team of researchers from the Embryology and Reproductive Medicine Units at Instituto Bernabeu in Madrid and Alicante have completed a study of the factors that may have the greatest impact on embryo transfer rates following a cycle of assisted reproduction. The research work was presented at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in late October in Cáceres.
The aim of research work performed by the Genetics and Molecular Biology Department at Instituto Bernabeu IBBiotech was to determine if there is a relationship between the ovarian stimulation process in cycles of in vitro fertilisation (IVF) and the aneuploidy and mosaicism rate in embryos. The conclusions were presented at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in October in Cáceres.
Instituto Bernabeu gave an oral communication about oocyte vitrification at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres in October. Freezing is common practice during in vitro fertilisation (IVF) treatment because it increases the available number of blastocysts for analysis.
Instituto Bernabeu’s strive for excellence is clearly marked out in a meticulous work method and implementation of the most demanding healthcare and process quality controls with the aim of always achieving excellent results. The healthcare that patients are given is endorsed by certifications and accreditations awarded to the clinic by independent entities. Instituto Bernabeu Group has recently been awarded the QH* accreditation. It entails not only a renewal of the Quality Healthcare (QH) certification, but also an additional, higher level that has been driven by the ‘increase in the validity of certain certifications’, as highlighted by the Institute for Development and Integration of Health (IDIS), the accrediting organism.
Instituto Bernabeu gave an oral communication at the European Society of Human Reproduction and Embryology (ESHRE) Congress entitled ‘The luteal phase of double ovarian stimulation treatment (DuoStim) provides higher oocyte and blastocyst yield in unselected infertile patients: a retrospective, same-patient, cohort study.’ This study is included in the articles that Merck has featured in its specialist journal focussing on fitting publications that is released following the scientific gathering focussing on fitting publications.
Instituto Bernabeu attended the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres and presented a study about the effect that segmental chromosomal aneuploidies have on the embryo.
Once again this year, Instituto Bernabeu attended the Association for the Study of Reproduction Biology (ASEBIR) Congress. It was held in Cáceres from 23rd to 25th October 2019. Nine items of research work performed by the Embryology Unit and the Molecular Biology and Genetics Department were presented at the national congress. It is the most significant congress of its kind in the field of reproduction biology.
Instituto Bernabeu attended the World of Microbiome Pregnancy, Birth and Infancy congress held in Milan, Italy from 31st October to 2nd November. Dr Belén Lledó, Scientific Director of IBBiotech presented Instituto Bernabeu’s pioneering research into the impact of the vaginal microbiome on the results of assisted reproduction treatment.
Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, moderated the Endometrial Receptivity Workshop held within the framework of the 4th Clinical Workshops on Reproduction Medicine organised by Ferring and held in Valencia on 8th and 9th November.
Instituto Bernabeu has submitted a pilot study involving ova donors to the European Society of Human Reproduction and Embryology (ESHRE). It researches differences in results when conventional ovarian stimulation protocols are applied in comparison with new, no fixed time stimulation protocols that do not take the stage of the menstrual cycle into account. The research entailed an analysis of ova donation cycles which was performed over ten months. It compared stimulation beginning on days 1 to 3 with ovarian stimulation that had no fixed time from day 4 onwards.
The Rafael Bernabeu Social Welfare Foundation has published the results of the 2018-2019 scholarships awards. The scholarships provide Medicine, Nursing, Biology and Biotechnology students in Spain with financial support in order boost their studies. On this occasion, further to assessment of all the applications that were received, the Awards Committee chose to award four students the scholarships worth a total of 10,000 euros.
Instituto Bernabeu participated in the 75th edition of the American Society for Reproductive Medicine (ASRM) congress held from 12th to 16th October in Philadelphia. It is one of the leading congresses in the world both in terms of the number of participants and in terms of the quality of the work that is presented there. Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, was the clinic representative at the global gathering of experts attended by 9,300 people from 94 countries. It is a not-to-be-missed event in the field.
The recent international congress Meeting The Experts provided relevant reviews and information on the latest scientific advances in the treatment of reproductive problems. We were able to interview all the speakers that clarified these aspects. Here are all the videos of the interviews to broaden and complete their contribution.
Dr Rafael Bernabeu, Medical Director of Instituto Bernabeu, has addressed medical and healthcare aspects of cross-border reproductive medicine in a gathering of experts in law organised by the University of Alicante (UA). The seminar, entitled ‘Multi-disciplinary outlooks for studying healthcare in cross-border reproduction’, was held on 23rd September and gynaecologist Dr Bernabeu delivered the specialist’s point of view on the subject. The event was organised by the Department of Civil Law and it was attended by full professors and associate professors in Sociology and Civil Law.
Pharmacogenetics and Genomics, a specialist journal, recently published Instituto Bernabeu research work into ovarian reserve and pharmacogenetics, a subject in which the clinic is a leading entity and pioneer. The research was managed by Dr Belén Lledó, Scientific Director of Instituto Bernabeu Biotech, and it addressed the relevance of individual screening of the genetic variants in terms of ovarian response prediction. The aim was to determine if the polymorphisms in some genes involved in ovarian follicle maturation can predict ovarian response.
The Journal of Assisted Reproduction and Genetics (JARG) has cited the conclusions that were reached during the research
Instituto Bernabeu has brought the third edition of the international Meeting the Experts event for specialists in the field of reproductive medicine (27th and 28th September) to a close. The event was held in the Alicante facilities and 140 experts including gynaecologists, geneticists, biologists, molecular biologists, pharmacists and artificial intelligence specialists from China, USA, Australia, Israel, Belgium, Norway, Denmark, England, Italy and Switzerland met there to exchange knowledge and experiences.
Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, participated in Next Now Theramex Fertility held in Valencia on 20th and 21st September. International experts in the field attended the professional event. Dr Llácer, who is a gynaecologist, addressed the impact of genetic polymorphisms on ovarian response. Poor ovarian reserve is one of the most common issues in the field of reproductive medicine and Dr Llácer is a renowned specialist in this area. He manages the department dedicated to this issue at Instituto Bernabeu.
Instituto Bernabeu has submitted research work about optimisation of ovarian stimulation in oocyte donation cycles to the European Society of Human Reproduction and Embryology (ESHRE). The research involves using oral progesterone instead of the GnRH antagonist, the alternative pharmaceutical drug that has traditionally been used to control when ovulation takes place. The main advantage of this strategy is how easy it is for patients because it entails fewer injections.
Dr Jorge Ten, Manager of the Embryology Unit at Instituto Bernabeu, will participate today, Tuesday 17th September, in a CooperSurgical workshop held in Valencia and entitled ‘Experiences using LifeGlobal Total LP (5mg) Culture Media’. The event on embryo culture brings together embryology managers so that they can present their experience and most recent results with this embryo culture and transfer medium.
The August 2019 issue of the Journal of Assisted Reproduction and Genetics (JARG) referenced research work about abnormal sperm analysis using the FISH (fluorescence in situ hybridisation) diagnosis technique and in which Instituto Bernabeu is participating. This specialist journal, which is published by the American Society of Reproductive Medicine (ASRM), accepted the research on the use of FISH in assisted reproduction techniques which involves analysis of part of the chromosomal make-up of spermatozoa.
Instituto Bernabeu has submitted research work to the European Society of Human Reproduction and Embryology (ESHRE), the leading worldwide entity in the field of reproductive medicine. The purpose of the research was to understand if using Embryoglue® as the culture medium for embryo transfer to the mother's uterus improves results.